Latest news with #SEK2.19B
Yahoo
28-05-2025
- Business
- Yahoo
Patria Bank And 2 Other Promising European Penny Stocks
As European markets experience a boost in sentiment following the de-escalation of trade tensions between the U.S. and China, investors are increasingly looking for opportunities within this landscape. Penny stocks, despite their somewhat outdated name, continue to represent a compelling area for those interested in smaller or newer companies that might offer growth potential at lower price points. By focusing on stocks with strong financial foundations and solid fundamentals, investors can uncover hidden gems that may provide both stability and potential upside in today's market conditions. Name Share Price Market Cap Financial Health Rating Bredband2 i Skandinavien (OM:BRE2) SEK2.29 SEK2.19B ★★★★☆☆ Transferator (NGM:TRAN A) SEK2.59 SEK237.32M ★★★★★☆ Angler Gaming (NGM:ANGL) SEK3.58 SEK268.45M ★★★★★★ Hifab Group (OM:HIFA B) SEK3.70 SEK225.1M ★★★★★★ IMS (WSE:IMS) PLN3.69 PLN125.07M ★★★★☆☆ Cellularline (BIT:CELL) €2.59 €54.63M ★★★★★☆ Netgem (ENXTPA:ALNTG) €0.986 €33.02M ★★★★★★ Fondia Oyj (HLSE:FONDIA) €4.75 €17.76M ★★★★★★ Mistral Iberia Real Estate SOCIMI (BME:YMIB) €1.01 €22M ★★★★★☆ Deceuninck (ENXTBR:DECB) €2.16 €298.22M ★★★★★★ Click here to see the full list of 440 stocks from our European Penny Stocks screener. Let's take a closer look at a couple of our picks from the screened companies. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Patria Bank SA is a credit institution offering banking and financial services to individuals, SMEs, agribusinesses, and corporate clients in Romania with a market cap of RON272.14 million. Operations: Patria Bank SA does not report specific revenue segments. Market Cap: RON272.14M Patria Bank SA has shown significant earnings growth, with a 39.7% increase over the past year, outpacing the industry average. Its net profit margins have improved to 18.4%, and it maintains high-quality earnings. The bank's funding is primarily low-risk due to customer deposits, and its loans-to-deposits ratio of 66% is considered appropriate. Despite a high level of bad loans at 5.1%, its allowance for these is low at 95%. Recent earnings reports show continued growth in net income and interest income, reflecting stability in financial performance amidst market volatility. Click here to discover the nuances of Patria Bank with our detailed analytical financial health report. Explore Patria Bank's analyst forecasts in our growth report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Turbomecanica SA is a company that manufactures and sells engines, mechanical assemblies, and equipment for aircraft and helicopters across Europe and Asia, with a market cap of RON150.36 million. Operations: The company's revenue is primarily derived from the repairs of engines, which account for RON99.56 million, followed by the manufacturing of aircraft parts at RON31.43 million. Market Cap: RON150.36M Turbomecanica SA has demonstrated robust earnings growth, with a 45% increase over the past year, surpassing the Aerospace & Defense industry average. The company's net profit margins improved to 11.5%, while its price-to-earnings ratio of 9.3x suggests it might be undervalued compared to the broader Romanian market. Turbomecanica's short-term assets comfortably cover both its short and long-term liabilities, indicating financial stability. However, while debt levels have risen slightly over five years, they remain well-managed with operating cash flow covering debt obligations effectively. Despite a stable dividend yield of 5.99%, it's not fully supported by free cash flows. Get an in-depth perspective on Turbomecanica's performance by reading our balance sheet health report here. Explore historical data to track Turbomecanica's performance over time in our past results report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Kerlink SA offers network infrastructure solutions for the Internet of Things (IoT) to operators, businesses, and utilities across various regions including Europe, the Middle East and Africa, the Asia-Pacific, and the Americas, with a market cap of €5.87 million. Operations: The company's revenue is divided into two main segments: Private Networks (Including Reference Design) generating €10.92 million and Historic and Alternative Telecom Operators contributing €0.75 million. Market Cap: €5.87M Kerlink SA, with a market cap of €5.87 million, operates in the IoT network infrastructure space and recently reported full-year sales of €11.67 million, down from the previous year. Despite being unprofitable with a net loss of €3.77 million, Kerlink has managed to reduce its losses over five years by 15% annually and maintains a positive free cash flow that supports a cash runway exceeding three years. The company's short-term assets exceed both short- and long-term liabilities, indicating some financial resilience despite high debt levels with a net debt to equity ratio at 177.9%. Jump into the full analysis health report here for a deeper understanding of Kerlink. Examine Kerlink's earnings growth report to understand how analysts expect it to perform. Click through to start exploring the rest of the 437 European Penny Stocks now. Seeking Other Investments? The end of cancer? These 23 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BVB:PBK BVB:TBM and ENXTPA:ALKLK. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
15-05-2025
- Business
- Yahoo
3 European Penny Stocks With A Market Cap Of €20M
As European markets continue to navigate a landscape marked by mixed performances and hopes for easing trade tensions, investors are increasingly seeking opportunities in less conventional areas. Penny stocks, although an outdated term, highlight smaller or newer companies that can offer significant potential at lower price points. By focusing on those with strong financials and solid fundamentals, investors may uncover hidden gems with the promise of growth and stability amidst current market conditions. Name Share Price Market Cap Financial Health Rating Bredband2 i Skandinavien (OM:BRE2) SEK2.285 SEK2.19B ★★★★☆☆ Transferator (NGM:TRAN A) SEK3.13 SEK300.72M ★★★★★☆ Angler Gaming (NGM:ANGL) SEK3.80 SEK284.94M ★★★★★☆ Hifab Group (OM:HIFA B) SEK3.46 SEK210.5M ★★★★★★ IMS (WSE:IMS) PLN3.71 PLN125.75M ★★★★☆☆ AMSC (OB:AMSC) NOK1.464 NOK105.21M ★★★★★★ Cellularline (BIT:CELL) €2.65 €55.89M ★★★★★☆ Netgem (ENXTPA:ALNTG) €0.98 €32.82M ★★★★★★ Fondia Oyj (HLSE:FONDIA) €4.63 €17.31M ★★★★★★ Deceuninck (ENXTBR:DECB) €2.23 €307.88M ★★★★★★ Click here to see the full list of 449 stocks from our European Penny Stocks screener. Below we spotlight a couple of our favorites from our exclusive screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: DigiTouch S.p.A. offers digital marketing and transformation services in Italy, with a market cap of €24.18 million. Operations: The company generates revenue through three main segments: Technology Services (€24.13 million), Marketing Services (€11.49 million), and E-Commerce Services (€3.24 million). Market Cap: €24.18M DigiTouch S.p.A., with a market cap of €24.18 million, operates in digital marketing and transformation services, generating revenues from technology (€24.13M), marketing (€11.49M), and e-commerce services (€3.24M). Despite facing a slight decline in sales from €44.11 million to €40.01 million over the past year, the company maintains stable financial health with short-term assets exceeding liabilities and satisfactory net debt to equity ratio at 37.5%. Earnings growth is forecasted at 22.59% annually, supported by an experienced management team and board of directors while offering dividends of €0.0300 per share payable June 2025. Click to explore a detailed breakdown of our findings in DigiTouch's financial health report. Understand DigiTouch's earnings outlook by examining our growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: ATEME SA, along with its subsidiaries, is involved in the production and sales of electronic and computer devices and instruments globally, with a market cap of €48.49 million. Operations: The company generates revenue from the marketing of professional compression and video broadcasting solutions, amounting to €93.50 million. Market Cap: €48.49M ATEME, with a market cap of €48.49 million, is facing challenges as it remains unprofitable with increasing losses over the past five years. Despite generating €93.50 million in sales last year, its net loss widened to €5.38 million from the previous year. The company's high net debt to equity ratio of 68.4% raises concerns about financial leverage, though it has sufficient cash runway for over three years if maintaining its current free cash flow level. Recent developments include showcasing cloud-based broadcast technology at NAB 2025, highlighting potential efficiencies and cost savings for broadcasters transitioning to ATSC 3.0 standards. Take a closer look at ATEME's potential here in our financial health report. Learn about ATEME's future growth trajectory here. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Medivir AB (publ) is a pharmaceutical company that develops and commercializes cancer treatments in the Nordic region, Europe, and internationally, with a market cap of SEK207.51 million. Operations: The company generates revenue of SEK3.58 million from its pharmaceuticals segment. Market Cap: SEK207.51M Medivir AB, with a market cap of SEK207.51 million, is navigating the challenges typical of pre-revenue biotech firms. The company reported minimal revenue of SEK0.8 million for Q1 2025 and continues to be unprofitable, with a net loss narrowing to SEK13.3 million from the previous year. Despite financial hurdles, Medivir has made significant strides in its oncology pipeline, securing a European patent for its fostroxacitabine bralpamide combination therapy until 2041 and presenting promising phase 1b/2a trial results for advanced liver cancer treatment at an international summit, indicating potential future growth opportunities in this niche market. Get an in-depth perspective on Medivir's performance by reading our balance sheet health report here. Examine Medivir's earnings growth report to understand how analysts expect it to perform. Dive into all 449 of the European Penny Stocks we have identified here. Ready For A Different Approach? Uncover 16 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BIT:DGT ENXTPA:ATEME and OM:MVIR. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
